Loading...
Back to narrative

CI: Significant Buybacks And 2026 Guidance Will Drive Upside Momentum

Update shared on 16 Nov 2025

Fair value Decreased 5.93%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-18.3%
7D
-0.5%

Narrative Update on Cigna Group

Analysts have lowered their price target for Cigna Group from $349.04 to $328.35. This change reflects adjustments for a slightly higher discount rate as well as revised expectations for revenue growth and profit margins.

What's in the News

  • Cigna Group provided earnings guidance for 2026, expecting to grow EPS for the year (Company announcement).
  • The company completed the repurchase of over 133.5 million shares, representing 41.09% of shares, for $34.44 billion under its long-term buyback program announced in December 2018 (Company announcement).
  • Cleerly announced that Cigna will begin covering Cleerly LABS Advanced Plaque Analysis effective October 1, 2025. This will expand access to AI-enabled CT-based coronary imaging for patients meeting specific clinical criteria (Client announcement).
  • J.P. Morgan Securities LLC, U.S. Bancorp Investments, Inc., Wells Fargo Securities, LLC, and PNC Capital Markets LLC have all been added as Co-Lead Underwriters for Cigna Group's Fixed-Income Offering (Company announcement).

Valuation Changes

  • Consensus Analyst Price Target decreased from $349.04 to $328.35, reflecting a modest downward revision.
  • Discount Rate rose slightly, from 6.81% to 6.96%.
  • Revenue Growth expectations increased from 4.91% to 5.34%.
  • Net Profit Margin fell from 2.41% to 2.24%.
  • Future P/E ratio remained nearly unchanged, moving from 13.55x to 13.53x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.